文献速递角膜与眼表疾病

限制阿片类药物处方与角膜术后阿片使用的关系

Association of Limiting Opioid Prescriptions With Use of Opioids After Corneal Surgery.
PubMed 文献 · JAMA Ophthalmol · 2020-01-01

这项前瞻性队列研究纳入82例角膜手术患者,比较了更新阿片处方指南前后两个队列的阿片类药物使用情况。结果显示,第二队列处方片数更少(平均6.6 vs 18.8片),实际使用片数也更少(平均4.0 vs 8.3片),且疼痛控制仍充分,但多数患者未妥善处理剩余药片。

要点

  • 减少角膜术后阿片处方片数未影响疼痛控制,且患者实际使用片数更少。
  • 接受较少片数的患者剩余药片显著减少,但多数仍未妥善处置剩余药物。
  • 角膜术后阿片使用需求低于传统处方量,指南更新可安全减少处方。

核心结论

  • 评估阿片需求后医生减少处方片数,患者疼痛控制仍充分且使用片数更少,但剩余药片未妥善处置。

研究设计与样本

  • 前瞻性队列研究,纳入82例角膜手术成人患者,分为指南更新前第一队列(38/42)和更新后第二队列(44/70)。

主要发现

  • 第一队列处方片数显著多于第二队列(平均18.8 vs 6.6片,差值12.2,95%CI 10.4-14.0,P<.001)。
  • 第一队列使用片数显著多于第二队列(平均8.3 vs 4.0片,差值4.3,95%CI 1.4-7.2,P=.005)。
  • 第一队列剩余片数显著多于第二队列(平均10.3 vs 2.9片,差值7.5,95%CI 4.7-10.2,P<.001)。
  • 第二队列详细调查中,19/27例(70%,95%CI 50%-86%)疼痛控制充分,6/27例(22%,95%CI 9%-42%)超过所需。
  • 第二队列28例中20例(71%,95%CI 55%-88%)有剩余片数,其中17/20例(85%,95%CI 62%-97%)未处置,3/20例(15%,95%CI 3%-38%)丢弃或冲走。

临床怎么用

  • 角膜术后可依据评估减少阿片处方片数,而不影响疼痛控制。
  • 应加强患者教育,指导妥善处置剩余阿片类药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Opioids, which carry a high risk for addiction and overdose, are commonly prescribed after corneal surgery. Data are lacking describing opioid prescribing practices and opioid needs by patients after ophthalmic surgery. OBJECTIVES: To quantify opioid use and to assess the association of decreasing the number of opioid tablets prescribed after corneal surgery with postsurgical use. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study investigated opioid use after corneal surgery using direct interviews of 2 adult patient cohorts separated by an updated opioid prescribing guideline. The first cohort survey assessed the quantity of opioid tablets used after surgery. The cornea division of a tertiary care academic medical center reviewed the use needs and decreased the number of tablets prescribed after routine cases. Simultaneously, a statewide opioid monitoring program began that provided patients with opioid information. A second unique cohort received a more detailed survey to assess use, opioid disposal, and pain control. Data for the first cohort were collected from December 1, 2017, through January 19, 2018; for the second cohort, from June 1 to September 15, 2018. Data were analyzed from October 24, 2018, through September 24, 2019. EXPOSURE: Corneal surgery. MAIN OUTCOMES AND MEASURES: Differences in use of opioid tablets used by both patient cohorts, assessed using the 2-sample t test. RESULTS: Of 112 eligible, contacted patients, 82 consented to participate (42 men [51%]; mean [SD] age, 42.5 [17.8] years) and were included in the analysis; 38 of 42 participated in the first cohort and 44 of 70 participated in the second cohort. Of those receiving opioid prescriptions, the first cohort was prescribed significantly more tablets than the second cohort (mean [SD], 18.8 [4.2] vs 6.6 [3.1]; difference, 12.2 [95% CI, 10.4-14.0]; P < .001). The first cohort used significantly more tablets than the second cohort (mean [SD], 8.3 [7.0] vs 4.0 [3.2]; difference, 4.3 [95% CI, 1.4-7.2]; P = .005) and had significantly more leftover tablets (mean [SD], 10.3 [6.9] vs 2.9 [2.7]; difference, 7.5 [95% CI, 4.7-10.2]; P < .001). In the detailed survey for the second cohort, 19 of 27 patients reported pain control as adequate (70% [95% CI, 50%-86%]); 6 of 27, as more than needed (22% [95% CI, 9%-42%]). Twenty of 28 participants (71% [95% CI, 55%-88%]) had leftover tablets; 17 of these (85% [95% CI, 62%-97%]) did not dispose of leftovers, and 3 (15% [95% CI, 3%-38%]) threw away or flushed leftovers. CONCLUSIONS AND RELEVANCE: After an assessment of opioid needs, physicians prescribed fewer opioid pills. However, patients who underwent cornea surgery and received fewer tablets continued to have adequate pain control and used even fewer tablets compared with the initial cohort. Patients with unused opioid tablets did not dispose of them properly.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Woodward MA, Zhang Y, Tannen B, et al. Association of Limiting Opioid Prescriptions With Use of Opioids After Corneal Surgery. JAMA Ophthalmol. 2020. PMID: 31670751. doi:10.1001/jamaophthalmol.2019.4432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。